Developing effective therapies for pediatric populations involves unique and complex challenges. Key considerations include medication acceptance, patient-centered adherence strategies, and the pharmacokinetic and pharmacodynamic (PK/PD) challenges arising from the rapid anatomical and physiological development of pediatric patients. Additionally, pediatric medicine faces constraints such as a limited market size, complex formulation requirements, and specific regulatory demands.
In this interview, Srinivasan Shanmugam, PhD, Adare’s Executive Director of Pharmaceutical Sciences, provides expert insights on these important topics.